Ticker Symbol: RGEN
Repligen Corp.
$268.98 - 20-11-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0000730272
Company Profile
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological drugs. Its primary customers are biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Its corporate headquarters are located in Waltham, Massachusetts, with additional administrative and manufacturing operations worldwide. The majority of its manufacturing sites are located within the U.S. (California, Massachusetts, New Jersey and New York), and outside of the U.S. it has sites in Estonia, Germany, Ireland, the Netherlands and Sweden.
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: 41 Seyon St Bldg 1 Ste 100
Website: www.repligen.com
CEO: Anthony Hunt
Tags:
- Health Technology
- Biotechnology
- Pharmaceuticals: Major
- Manufacturing
- Biological Product (except Diagnostic) Manufacturing
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $152.74
Change:
-$1.98
(
-1.28%)
Days Range: $151.55 - $158.37
Beta: 1.50
52wk. High: $212.17
52wk. Low: $134.63
Ytd. Change -11.07%
50 Day Moving Average: $157.87
200 Day Moving Average: $160.77
Shares Outstanding: 55756322
Valuation
Market Cap: 851.6B
PE Ratio: 63.12
EPS (TTM): 2.42
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A